BioLife Solutions BLFS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on invested capital | -4.9%+0.5pp | -5.4%-0.3pp | -5%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.2×0.0× | 0.2×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 7.3×+1.4× | 5.9×+1.3× | 4.7×+0.2× | 4.4×-0.3× | 4.7×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $7.56-1.1% | $7.64+5.3% | $7.260.0% | $7.26-0.4% | $7.29-3.7% | |
| Valuation | ||||||
| Market capitalization | $1.25B+33.1% | $1.16B-4.7% | $1.22B+17.9% | $1.04B-3.2% | $1.07B-11.0% | |
| Price / sales | 12.5×+0.5× | 12.3×-1.1× | 13.5×— | —— | —— | |
| Price / book | 3.6×+0.7× | 3.1×-0.3× | 3.5×+0.5× | 3×-0.1× | 3×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioLife Solutions's profit margins?
- BioLife Solutions (BLFS) runs a 66.9% gross margin and a -16.7% operating margin, with a -68.7% net margin.
- Where do BioLife Solutions's ratios come from?
- Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
